Literature DB >> 12595067

NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium.

Rupika Delgoda1, Lu Yun Lian, James Sandy, Edith Sim.   

Abstract

Arylamine N-acetyltransferases (NAT) are a family of enzymes found in both eucaryotes and procaryotes, which catalyse the N-acetylation of a range of arylamine and hydrazine drugs and carcinogenic arylamines, using acetyl Coenzyme A as a cofactor. Here we describe a nuclear magnetic resonance (NMR) investigation of the interaction of substrates with Salmonella typhimurium NAT. For solution NMR investigations, pure recombinant NAT from S. typhimurium was used at up to 0.1 mM. We demonstrate that a hydrazine substrate, isoniazid (INH), binds to the protein in the absence of the cofactor, acetyl CoA, and thereby suggest that even though the catalysis may follow a ping-pong pathway, ligand-enzyme interactions can occur in the absence of acetyl CoA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595067     DOI: 10.1016/s0304-4165(02)00500-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase.

Authors:  Isaac M Westwood; Simon J Holton; Fernando Rodrigues-Lima; Jean-Marie Dupret; Sanjib Bhakta; Martin E M Noble; Edith Sim
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

2.  Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis.

Authors:  James Sandy; Simon Holton; Elizabeth Fullam; Edith Sim; Martin Noble
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

3.  Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.

Authors:  James Sandy; Adeel Mushtaq; Simon J Holton; Pamela Schartau; Martin E M Noble; Edith Sim
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance.

Authors:  Ricardo Martins Ramos; Janaína Menezes Perez; Luis André Baptista; Hermes Luís Neubauer de Amorim
Journal:  J Mol Model       Date:  2012-03-30       Impact factor: 1.810

5.  Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa.

Authors:  Isaac M Westwood; Edith Sim
Journal:  BMC Biochem       Date:  2007-03-20       Impact factor: 4.059

6.  Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.

Authors:  Nicola Laurieri; Akane Kawamura; Isaac M Westwood; Amy Varney; Elizabeth Morris; Angela J Russell; Lesley A Stanley; Edith Sim
Journal:  BMC Pharmacol Toxicol       Date:  2014-11-29       Impact factor: 2.483

7.  Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the Liver.

Authors:  Sheena Francis; Nicola Laurieri; Chukwuemeka Nwokocha; Rupika Delgoda
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

Review 8.  Arylamine N-acetyltransferases in mycobacteria.

Authors:  Edith Sim; James Sandy; Dimitrios Evangelopoulos; Elizabeth Fullam; Sanjib Bhakta; Isaac Westwood; Anna Krylova; Nathan Lack; Martin Noble
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

Review 9.  Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.

Authors:  E Sim; A Abuhammad; A Ryan
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.